{
    "url_original": "https://www.wsj.com/articles/fda-authorizes-pfizer-biontech-booster-for-12-to-15-year-olds-11641221427?mod=business_lead_pos3",
    "url": "fda-authorizes-pfizer-biontech-booster-for-12-to-15-year-olds-11641221427",
    "title": "FDA Authorizes Pfizer-BioNTech Booster for 12- to 15-Year-Olds",
    "sub_head": "The clearance of the extra dose could help bolster protection against Omicron",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2022-01-03 14:20:00",
    "body": "U.S. health regulators cleared use of a Covid-19 booster from  Pfizer Inc.  and  BioNTech SE  in adolescents 12 to 15 years old, expanding access to an extra dose that could bolster the fight against the Omicron variant.<br />For anyone now eligible to get the extra dose, the U.S. Food and Drug Administration said the Pfizer-BioNTech booster could be administered five months after their second shot, instead of the six months previously set."
}